Your browser doesn't support javascript.
loading
Understanding Physicians' Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach.
Qu, Haiyan; Silverman, Stuart L; Shewchuk, Richard M; Curtis, Jeffrey R; Austin, Shamly; Greenspan, Susan L; Nieves, Jeri W; Outman, Ryan C; Warriner, Amy H; Watts, Nelson B; Saag, Kenneth G.
  • Qu H; Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Silverman SL; Cedars-Sinai, Los Angeles, CA, USA.
  • Shewchuk RM; Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Curtis JR; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Austin S; Research, Development, & Analytics, Highmark Wholecare, Pittsburgh, PA, USA.
  • Greenspan SL; Division of Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Nieves JW; Department of Epidemiology, Columbia University, New York, NY, USA.
  • Outman RC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Warriner AH; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Watts NB; Mercy Health, Cincinnati, OH, USA.
  • Saag KG; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Risk Manag Healthc Policy ; 15: 1293-1302, 2022.
Article en En | MEDLINE | ID: mdl-35818434
ABSTRACT

Objective:

Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an empirical framework for patient-identified barriers to osteoporosis medication initiation and adherence from physician experts.

Methods:

A cognitive mapping approach involving nominal group technique (NGT) meetings and a card sorting and rating task were used to obtain formative data. We first conducted four NGT meetings with 18 women patients who were not on osteoporosis treatment to identify barriers to osteoporosis medication, then invited 27 osteoporosis physicians to sort and rate 25 patients identified barriers. Descriptive analysis, multidimensional scaling analysis, and hierarchical cluster analysis were applied for data analysis.

Results:

A two-dimensional five-cluster cognitive map was derived to provide an organizational framework for understanding patients perceived barriers to medication initiation and adherence. The five clusters were concerns about side effects, experience of side effects, lifestyle changes, medication access and complexity, and patient uncertainty about treatment and trust in the provider. The two dimensions were interpreted as internal to patients (X-axis) and external to patients (Y-axis). Conclusions/Implications Views of patients solicited in a structured format provided directions to help in designing interventions to improve osteoporosis medication initiation and adherence.
Palabras clave